For example, ITDs in FLT3 are discovered in ∼20%–30% of patients with acute myeloid leukemia (AML) and have been associated with increased relapse risk and decreased overall survival [2, 3]. The gene discussed is FLT3; the disease is acute myeloid leukemia.